Poland· PL-100102683
Cyclo 3 Fort
A capillary stabilizing agents product containing produkt złożony, registered in Poland by Pierre Fabre Medicament. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Produkt złożony is registered in 2 of 19 countries.
Countries holding a registration under ATC C05C (capillary stabilizing agents), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Produkt złożony · ATC C05C
2 / 19 countries
- Belgiumprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Produkt złożony
- Manufacturer
- Pierre Fabre Medicament
- Country
- Poland (PL)
- ATC code
- C05C
- ATC class
- CAPILLARY STABILIZING AGENTS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990884315
- gtin05909991034450
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C05C
Capillary stabilizing agents, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/058152da-f091-489d-92e6-ae308d109d6b GET /v1/drugs/058152da-f091-489d-92e6-ae308d109d6b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "-",
"packaging": "05909990884315 ¦ OTC ¦ 53414\n30 kaps.\n05909991034450 ¦ OTC ¦ 81601\n60 kaps.",
"substance": "Rusci aculeati extractum siccum 150 mg + Metylochalkon hesperydyny 150 mg + Acidum ascorbicum 100 mg",
"common_name": "Produkt złożony",
"pl_product_id": "100102683",
"pozwolenie_nr": "08843",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about produkt złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.